Effects of Clofibrate Treatment in Pigs on Liver Health
Author Information
Author(s): Luci Sebastian, Giemsa Beatrice, Hause Gerd, Kluge Holger, Eder Klaus
Primary Institution: Institut für Agrar- und Ernährungswissenschaften, Martin-Luther-Universität Halle-Wittenberg
Hypothesis
Clofibrate treatment in pigs will affect liver parameters related to peroxisome proliferation and oxidative stress.
Conclusion
Clofibrate treatment induces moderate peroxisome proliferation in pigs without causing oxidative stress, while stimulating apoptosis and increasing proto-oncogene expression.
Supporting Evidence
- Pigs treated with clofibrate had heavier livers and higher peroxisome counts compared to control pigs.
- Clofibrate treatment increased mRNA concentrations of pro-apoptotic genes in the liver.
- Hydrogen peroxide levels were lower in clofibrate-treated pigs than in controls.
- Gene expression of proto-oncogenes c-myc and c-jun was higher in clofibrate-treated pigs.
Takeaway
Researchers gave pigs a medicine called clofibrate to see how it affects their livers. They found that it made the livers a bit bigger and changed some important genes, but it didn't hurt the liver with stress.
Methodology
Eighteen male pigs were fed a diet with clofibrate for 28 days, and various liver parameters were measured.
Potential Biases
Potential bias in the selection of pigs and the controlled feeding system may affect the results.
Limitations
The study was conducted on a small sample size and only in male pigs, which may limit the generalizability of the findings.
Participant Demographics
Eighteen male crossbred pigs aged 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website